<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Otomycosis - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-name-link {
            color: inherit;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
        }

        .item-name-link:hover {
            text-decoration-thickness: 2px;
        }

        .missing-disease-name {
            color: #991b1b;
            border-bottom: 1px dotted #dc2626;
        }

        .curation-gap-badge {
            display: inline-flex;
            align-items: center;
            margin-left: 8px;
            padding: 2px 8px;
            border-radius: 999px;
            font-size: 0.72rem;
            font-weight: 700;
            letter-spacing: 0.01em;
            text-transform: uppercase;
            background: #fef2f2;
            border: 1px solid #fecaca;
            color: #b91c1c;
            vertical-align: middle;
        }

        .missing-ontology-link {
            color: #b91c1c !important;
            text-decoration: underline dotted;
            text-underline-offset: 2px;
        }

        .dismech-inline-link {
            margin-left: 6px;
            font-size: 0.78rem;
            font-weight: 600;
            color: #0369a1;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
            white-space: nowrap;
        }

        .dismech-inline-link:hover {
            text-decoration-thickness: 2px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "‚Ü≥ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Otomycosis</span>
        </nav>

        <header class="page-header">
            <h1>Otomycosis</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Infectious</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0000262" target="_blank">
                        MONDO:0000262
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Otitis externa</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Fungal infection</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Otomycosis is a superficial fungal infection of the external auditory canal, commonly caused by Aspergillus and Candida species. It accounts for approximately 5-25% of otitis externa cases worldwide, with higher prevalence in tropical and subtropical climates. Predisposing factors include prior antibiotic or steroid ear drop use, trauma from ear cleaning, and humid environments. Clinical features include pruritus, otalgia, otorrhea, and conductive hearing loss due to fungal debris obstructing the ear canal. Otomycosis is increasingly recognized as a biofilm-related infection, which contributes to treatment failure and recurrence. Management centers on thorough aural toilet followed by topical antifungal agents.

            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <a class="stat-link" href="#definitions">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Definitions</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <a class="stat-link" href="#differentials">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Differentials</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <a class="stat-link" href="#trials">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Trials</div>
            </div>
            </a>
            
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">infectious disease</span>
                    
                    <span class="tag tag-classification">fungal infectious disease</span>
                    
                </div>
            </div>
            
            
            
            
            
            
        </div>
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        
        <div class="card" id="definitions">
            <div class="card-header">
                <div class="card-icon" style="background: #cffafe; color: #0e7490;">üìò</div>
                <h2 class="card-title">Definitions</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box definition-box">
                <div class="item-name">Clinical diagnostic criteria for otomycosis</div>
                
                <div class="item-desc">Otomycosis is diagnosed clinically based on characteristic otoscopic findings combined with symptomatology and confirmed by mycological culture. No single internationally standardized diagnostic criteria set exists; diagnosis relies on the triad of compatible symptoms, characteristic otoscopic appearance, and positive fungal culture or microscopy.
</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-classification">DIAGNOSTIC_CRITERIA</span>
                    
                    
                    <span class="tag tag-parent">adults and children</span>
                    
                </div>
                
    
    
                
    
    <div class="criteria-group">
        <div class="criteria-header">Inclusion criteria</div>
        <ul class="criteria-list">
            
            <li>
                <span class="criteria-term">External ear canal irritation symptoms</span>
                
                <span class="criteria-detail">Symptoms of external ear canal irritation including pruritus, otalgia, otorrhea, or aural fullness.
</span>
                
            </li>
            
            <li>
                <span class="criteria-term">Characteristic otoscopic findings</span>
                
                <span class="criteria-detail">Characteristic otoscopic findings including fungal debris, hyphae, spores, or conidiophores visible in the external auditory canal.
</span>
                
            </li>
            
            <li>
                <span class="criteria-term">Positive fungal identification</span>
                
                <span class="criteria-detail">Positive fungal culture or direct microscopy showing fungal elements (KOH preparation or Gram stain).
</span>
                
            </li>
            
        </ul>
    </div>
    
    
                
    
    <div class="criteria-group">
        <div class="criteria-header">Exclusion criteria</div>
        <ul class="criteria-list">
            
            <li>
                <span class="criteria-term">Middle ear pathology as primary source</span>
                
                <span class="criteria-detail">Otitis media or middle ear pathology as the primary source of symptoms.
</span>
                
            </li>
            
            <li>
                <span class="criteria-term">Necrotizing otitis externa</span>
                
                <span class="criteria-detail">Malignant otitis externa (necrotizing otitis externa) with bone involvement.
</span>
                
            </li>
            
        </ul>
    </div>
    
    
                
    
    
                
    
    
                
    
    
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"common presenting complaint was itchy ear (33.8%). Majority of patients (85.9%) had unilateral ear involvement"</div>
                
                
                <div class="evidence-explanation">Clinical study documenting the typical diagnostic presentation of otomycosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39376298" target="_blank">PMID:39376298</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide."</div>
                
                
                <div class="evidence-explanation">Systematic review establishing the clinical definition of otomycosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40317309" target="_blank">PMID:40317309</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"This study demonstrated that the diagnosis of otomycosis requires vigilance from clinicians given its nonspecific or minor symptoms."</div>
                
                
                <div class="evidence-explanation">RCT noting the diagnostic challenge of otomycosis due to nonspecific symptoms, supporting the need for systematic diagnostic criteria.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
                
            </div>
            
        </div>
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Disruption of cerumen antimicrobial barrier</div>
                
                <div class="item-desc">The external auditory canal is normally protected by cerumen, which maintains an acidic pH (mean ~3.95), contains antimicrobial peptides (defensins hBD1-3, cathelicidin LL-37, lysozyme, lactoferrin, BPI), and supports colonization resistance by resident microbiota. Physical or chemical disruption of this barrier by excessive ear cleaning, moisture exposure, or other trauma removes the primary antimicrobial defense.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Epithelial cell of external acoustic meatus
                        
                        <a href="http://purl.obolibrary.org/obo/CL_1000434" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Antimicrobial humoral response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019730" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üì DECREASED
    </span>
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        External acoustic meatus
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001352" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21298458" target="_blank">PMID:21298458</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"All ten antimicrobial peptides are present in ear wax. Some of these proteins seem to be merelycell-bound in ear wax. Antimicrobial peptides in ear wax prevent bacteria and fungi from causing infections inthe external auditory canal."</div>
                
                
                <div class="evidence-explanation">Identifies antimicrobial peptides in cerumen that protect the EAC from fungal infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41596275" target="_blank">PMID:41596275</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Earwax is composed primarily of keratin secreted by epithelial cells and substances secreted by sweat and apocrine glands. It plays a key role in the physiology of the ear canal, maintaining a low pH, limiting moisture, and exhibiting antimicrobial properties."</div>
                
                
                <div class="evidence-explanation">Confirms cerumen&#39;s antimicrobial role through low pH and antimicrobial properties.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Antibiotic-induced dysbiosis of ear canal microbiota</div>
                
                <div class="item-desc">Ototopical antibiotic use is the most common predisposing factor for otomycosis, found in approximately 47% of cases. Antibiotics suppress commensal bacteria that normally compete with fungi for nutrients and ecological niches, creating a permissive environment for fungal overgrowth. The resulting dysbiosis shifts the microbial community from bacterial-dominated to fungal-dominated.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Antimicrobial humoral response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019730" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üì DECREASED
    </span>
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39376298" target="_blank">PMID:39376298</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Aspergillus was the most common species isolated."</div>
                
                
                <div class="evidence-explanation">Systematic review identifying Aspergillus as the most common pathogen in otomycosis, with ototopical antibiotics as the commonest predisposing factor.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"50.0% applied ototopic medications before presentation"</div>
                
                
                <div class="evidence-explanation">Clinical study documenting prior ototopical medication use as a predisposing factor in half of patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38450054" target="_blank">PMID:38450054</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Staphylococcus spp. (average abundance 29.05%) was the dominant bacteria and Aspergillus spp. (average abundance 90.68%) was the dominant fungus involved in otomycosis secretion."</div>
                
                
                <div class="evidence-explanation">Microbiome study demonstrating the dysbiotic shift in otomycosis, with Aspergillus dominating the fungal community and bacterial co-infection by Staphylococcus.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Fungal colonization of the external auditory canal</div>
                
                <div class="item-desc">Aspergillus and Candida species colonize the external auditory canal when the microenvironment becomes permissive. Aspergillus species (particularly A. niger and A. flavus) are the most commonly isolated pathogens, followed by Candida species (particularly C. parapsilosis and C. tropicalis). The species distribution varies by geographic region.
</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        External acoustic meatus
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001352" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39376298" target="_blank">PMID:39376298</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Aspergillus was the most common species isolated."</div>
                
                
                <div class="evidence-explanation">Systematic review confirming Aspergillus as the predominant causative agent.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"common fungal isolate was Aspergillus niger 9 (45.0%)."</div>
                
                
                <div class="evidence-explanation">Clinical study confirming A. niger as the most common fungal isolate.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Biofilm formation and antifungal resistance</div>
                
                <div class="item-desc">Colonizing fungi form biofilms on the ear canal epithelium. The biofilm extracellular matrix acts as a diffusion barrier that reduces antifungal drug penetration and mediates phenotypic drug resistance. This biofilm-mediated resistance contributes to treatment failure and recurrence rates of approximately 15%.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Biofilm formation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042710" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üë INCREASED
    </span>
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36080191" target="_blank">PMID:36080191</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-IN_VITRO">In Vitro</span>
                    
                </div>
                
                <div class="evidence-snippet">"the PLGA-NPs system can increase the bioavailability of PTB in Aspergillus section Nigri biofilm by overcoming the biofilm matrix barrier and delivering PTB to fungal cells."</div>
                
                
                <div class="evidence-explanation">Demonstrates that Aspergillus biofilm matrix acts as a barrier to antifungal agents, necessitating nanoparticle delivery to penetrate it.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36632528" target="_blank">PMID:36632528</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"otomycosis relapsed even after six months of continuous systemic antifungal treatment with therapeutic drug levels and without treatment interruption; and only resolved after application of topical voriconazole"</div>
                
                
                <div class="evidence-explanation">Case report demonstrating that biofilm-mediated resistance can cause otomycosis relapse despite prolonged systemic therapy, supporting the clinical significance of biofilm as a treatment barrier.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Local innate immune activation</div>
                
                <div class="item-desc">Fungal hyphae, spores, and biofilm debris provoke local innate immune activation in the external auditory canal. Neutrophils and other innate immune cells are recruited to the site, producing inflammatory mediators that cause tissue edema, erythema, and pain. The host defense response to fungus is activated but insufficient to clear the biofilm-protected infection.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Neutrophil
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000775" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Defense response to fungus
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0050832" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üë INCREASED
    </span>
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21298458" target="_blank">PMID:21298458</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"If this local defence system fails, infections of the external auditory canal may result."</div>
                
                
                <div class="evidence-explanation">Failure of the cerumen antimicrobial defense system leads to EAC infections with consequent inflammation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Canal obstruction and symptom manifestation</div>
                
                <div class="item-desc">The combination of fungal biomass (hyphae, spores, conidiophores), inflammatory exudate, and desquamated epithelium accumulates in the external auditory canal, producing the characteristic clinical symptoms of pruritus, otalgia, discharge, and conductive hearing impairment. The degree of obstruction correlates with the severity of hearing loss.
</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        External acoustic meatus
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0001352" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"common presenting complaint was itchy ear (33.8%). Majority of patients (85.9%) had unilateral ear involvement"</div>
                
                
                <div class="evidence-explanation">Clinical study documenting the symptomatic presentation of otomycosis including pruritus and laterality.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Fungal_colonization_of_the_external_auditory_canal[&#34;Fungal colonization of the external auditory canal&#34;]
    Local_innate_immune_activation[&#34;Local innate immune activation&#34;]
    Antibiotic_induced_dysbiosis_of_ear_canal_microbiota[&#34;Antibiotic-induced dysbiosis of ear canal microbiota&#34;]
    Disruption_of_cerumen_antimicrobial_barrier[&#34;Disruption of cerumen antimicrobial barrier&#34;]
    Canal_obstruction_and_symptom_manifestation[&#34;Canal obstruction and symptom manifestation&#34;]
    Biofilm_formation_and_antifungal_resistance[&#34;Biofilm formation and antifungal resistance&#34;]

    Disruption_of_cerumen_antimicrobial_barrier --&gt; Antibiotic_induced_dysbiosis_of_ear_canal_microbiota
    Antibiotic_induced_dysbiosis_of_ear_canal_microbiota --&gt; Fungal_colonization_of_the_external_auditory_canal
    Fungal_colonization_of_the_external_auditory_canal --&gt; Biofilm_formation_and_antifungal_resistance
    Biofilm_formation_and_antifungal_resistance --&gt; Local_innate_immune_activation
    Local_innate_immune_activation --&gt; Canal_obstruction_and_symptom_manifestation

    style Fungal_colonization_of_the_external_auditory_canal fill:#dbeafe
    style Local_innate_immune_activation fill:#dbeafe
    style Antibiotic_induced_dysbiosis_of_ear_canal_microbiota fill:#dbeafe
    style Disruption_of_cerumen_antimicrobial_barrier fill:#dbeafe
    style Canal_obstruction_and_symptom_manifestation fill:#dbeafe
    style Biofilm_formation_and_antifungal_resistance fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">3</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Ear<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Integument<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Constitutional<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Ear
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Conductive hearing impairment
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000405" target="_blank">
                                Conductive hearing impairment
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000405)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38375517" target="_blank">PMID:38375517</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"clotrimazole has the best or most significant effect on the treatment of otomycosis for patients suffering from pain, itching, swelling, and hearing loss."</div>
                
                
                <div class="evidence-explanation">Hearing loss listed as a core symptom of otomycosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Integument
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Pruritus
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000989" target="_blank">
                                Pruritus
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000989)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"common presenting complaint was itchy ear (33.8%)."</div>
                
                
                <div class="evidence-explanation">Pruritus was the most common presenting complaint in this clinical series.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38375517" target="_blank">PMID:38375517</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"clotrimazole has the best or most significant effect on the treatment of otomycosis for patients suffering from pain, itching, swelling, and hearing loss."</div>
                
                
                <div class="evidence-explanation">Itching listed as a core symptom of otomycosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Constitutional
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Ear pain
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0030766" target="_blank">
                                Ear pain
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0030766)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38375517" target="_blank">PMID:38375517</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"clotrimazole has the best or most significant effect on the treatment of otomycosis for patients suffering from pain, itching, swelling, and hearing loss."</div>
                
                
                <div class="evidence-explanation">Pain listed as a core symptom of otomycosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Aural toilet and debridement
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Thorough mechanical debridement of fungal debris from the external auditory canal is the cornerstone of treatment and essential for topical antifungal efficacy. The most common treatment modality used in clinical practice.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The most common treatment was local ear debridement and use of topical antifungal creams. Majority (91.5%) of the patients responded with resolution of fungal infection."</div>
                
                
                <div class="evidence-explanation">Clinical study confirming debridement plus topical antifungal as standard of care with 91.5% resolution.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40317309" target="_blank">PMID:40317309</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"In the lavage group, 48 (48/52, 92.30%) patients were cured with initial treatment after three months of follow-up"</div>
                
                
                <div class="evidence-explanation">RCT demonstrating that ear canal lavage alone achieves 92.30% cure rate, comparable to lavage plus topical antifungal.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Topical antifungal therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001573" target="_blank">
                            MAXO:0001573
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #5b21b6;">Drug:</strong>
                    
                    <span class="tag tag-treatment">
                        clotrimazole
                        
                        <a href="http://purl.obolibrary.org/obo/CHEBI_3764" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                    <span class="tag tag-treatment">
                        miconazole
                        
                        <a href="http://purl.obolibrary.org/obo/CHEBI_6923" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Topical clotrimazole is the most commonly used antifungal agent. Other options include miconazole and nystatin. Systemic triazoles (fluconazole, itraconazole) are reserved for severe or refractory disease.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38375517" target="_blank">PMID:38375517</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Eight studies had similar results and claimed that clotrimazole has the best or most significant effect on the treatment of otomycosis"</div>
                
                
                <div class="evidence-explanation">Review supporting clotrimazole as the most effective topical treatment for otomycosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The most common treatment was local ear debridement and use of topical antifungal creams."</div>
                
                
                <div class="evidence-explanation">Confirms topical antifungal creams as standard clinical practice.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41019825" target="_blank">PMID:41019825</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"In the 12th week after treatment, 76.34% of the 10% povidone-iodine group and 85.26% of the Clotrimazole group had a good response to treatment (p = 0.248)."</div>
                
                
                <div class="evidence-explanation">RCT showing clotrimazole achieves 85.26% response rate at 12 weeks, with povidone-iodine as a comparable alternative (76.34%, no significant difference).</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Acidifying agents
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #5b21b6;">Drug:</strong>
                    
                    <span class="tag tag-treatment">
                        acetic acid
                        
                        <a href="http://purl.obolibrary.org/obo/CHEBI_15366" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                    <span class="tag tag-treatment">
                        boric acid
                        
                        <a href="http://purl.obolibrary.org/obo/CHEBI_33118" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Acidifying agents such as 2% acetic acid or boric acid alcohol solutions are used as alternatives to antifungals, particularly for mild cases or antifungal-resistant species. They restore the acidic pH of the ear canal that inhibits fungal growth.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38375517" target="_blank">PMID:38375517</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"in the biomedical field, the re-emerging investigation attention is due to the statements of a number of mechanisms defending the use of acidifying agents to treat mycosis (of antifungal-resistant species)."</div>
                
                
                <div class="evidence-explanation">Supports acidifying agents as an alternative treatment approach, especially for resistant cases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Topical antibiotic use</div>
                
                
                <div class="item-desc">Prolonged use of ototopical antibiotics (with or without steroids) is the most common predisposing factor, disrupting the normal bacterial flora and permitting fungal overgrowth.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39376298" target="_blank">PMID:39376298</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Aspergillus was the most common species isolated."</div>
                
                
                <div class="evidence-explanation">Systematic review identifies Aspergillus as the predominant pathogen, with ototopical antibiotics as the commonest predisposing factor (47% pooled estimate).</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Humid tropical climate</div>
                
                
                <div class="item-desc">Hot, humid environments promote moisture retention in the ear canal, which disrupts cerumen function and provides a favorable niche for fungal growth.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39376298" target="_blank">PMID:39376298</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Most of the studies were conducted in tropical and sub-tropical countries."</div>
                
                
                <div class="evidence-explanation">Systematic review confirming tropical/subtropical predominance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Otomycosis is common in environments with hot, humid weather"</div>
                
                
                <div class="evidence-explanation">Clinical study confirming association with hot, humid environments.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Ear canal trauma from cleaning</div>
                
                
                <div class="item-desc">Compulsive ear cleaning and instrumentation damage the epithelial lining and remove protective cerumen, predisposing to fungal colonization.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38962337" target="_blank">PMID:38962337</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"50.0% applied ototopic medications before presentation"</div>
                
                
                <div class="evidence-explanation">Clinical study documenting prior medication use as a predisposing factor.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        
        <div class="card" id="differentials">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">üîÄ</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">4</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Otomycosis:
            </p>
            
            
            
            <div class="item-box differential-box">
                <div class="item-name">
                    
                    <span class="missing-disease-name" title="No Dismech page yet for this disease">Acute bacterial otitis externa</span>
                    <span class="curation-gap-badge">Not Yet Curated</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0001051" target="_blank" class="missing-ontology-link">
                            MONDO:0001051
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Bacterial otitis externa presents with similar symptoms of ear pain, discharge, and canal edema. It is typically caused by Pseudomonas aeruginosa or Staphylococcus aureus and produces purulent rather than fungal debris. Bacterial infection tends to cause more severe pain and canal edema than otomycosis.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Purulent discharge rather than fungal debris (hyphae, spores)</li>
                        
                        <li>More severe pain and canal edema</li>
                        
                        <li>Responds to topical antibiotics rather than antifungals</li>
                        
                        <li>Absence of characteristic fungal mat on otoscopy</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39376298" target="_blank">PMID:39376298</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide."</div>
                
                
                <div class="evidence-explanation">Otomycosis represents a subset of otitis externa, requiring differentiation from the more common bacterial form.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            
            
            <div class="item-box differential-box">
                <div class="item-name">
                    
                    <span class="missing-disease-name" title="No Dismech page yet for this disease">Seborrheic dermatitis</span>
                    <span class="curation-gap-badge">Not Yet Curated</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0006608" target="_blank" class="missing-ontology-link">
                            MONDO:0006608
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Seborrheic dermatitis of the external ear can mimic otomycosis with pruritus, scaling, and flaking. It involves Malassezia yeast but is a chronic inflammatory dermatosis rather than a true fungal infection of the canal.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Scaling and flaking extends to conchal bowl and postauricular area</li>
                        
                        <li>Absence of fungal hyphae or conidiophores on microscopy</li>
                        
                        <li>Responds to topical steroids and antifungal shampoos</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33112026" target="_blank">PMID:33112026</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Among the main dermatoses that can affect EAC seborrheic dermatitis, psoriasis, irritant or allergic contact dermatitis, chronic external otitis (atrial eczematoid dermatitis) and cutaneous lupus should be considered."</div>
                
                
                <div class="evidence-explanation">Clinical study identifying seborrheic dermatitis as the most common (56% of cases) erythematous-squamous dermatosis of the external auditory canal, presenting with symptoms overlapping otomycosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            
            
            <div class="item-box differential-box">
                <div class="item-name">
                    
                    <span class="missing-disease-name" title="No Dismech page yet for this disease">Contact dermatitis of the ear canal</span>
                    <span class="curation-gap-badge">Not Yet Curated</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0005480" target="_blank" class="missing-ontology-link">
                            MONDO:0005480
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Allergic or irritant contact dermatitis from hearing aids, ear drops, or earrings can present with pruritus, erythema, and discharge similar to otomycosis. History of allergen exposure and patch testing help differentiate.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>History of allergen or irritant exposure (hearing aids, ear drops, jewelry)</li>
                        
                        <li>Absence of fungal elements on microscopy and culture</li>
                        
                        <li>Responds to allergen avoidance and topical corticosteroids</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33112026" target="_blank">PMID:33112026</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Among the main dermatoses that can affect EAC seborrheic dermatitis, psoriasis, irritant or allergic contact dermatitis, chronic external otitis (atrial eczematoid dermatitis) and cutaneous lupus should be considered."</div>
                
                
                <div class="evidence-explanation">Clinical study listing allergic contact dermatitis among the main erythematous-squamous disorders of the EAC that must be differentiated from infectious causes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1601193" target="_blank">PMID:1601193</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Hearing aid users with longstanding and severe dermatitis in the ear canal were examined by a dermatologist and patch tested."</div>
                
                
                <div class="evidence-explanation">Study documenting allergic contact dermatitis from hearing aid earmolds causing ear canal dermatitis, a key differential for otomycosis in hearing aid users.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            
            
            <div class="item-box differential-box">
                <div class="item-name">
                    
                    <span class="missing-disease-name" title="No Dismech page yet for this disease">Cholesteatoma</span>
                    <span class="curation-gap-badge">Not Yet Curated</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0006530" target="_blank" class="missing-ontology-link">
                            MONDO:0006530
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Cholesteatoma can present with chronic otorrhea, hearing loss, and debris in the ear canal. Unlike otomycosis, it involves keratinized squamous epithelium in the middle ear and can cause bone erosion and serious complications.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Pearly white keratin mass typically arising from the pars flaccida</li>
                        
                        <li>Associated with chronic otitis media and tympanic membrane perforation</li>
                        
                        <li>CT imaging shows soft tissue mass with possible bone erosion</li>
                        
                        <li>Requires surgical management rather than topical antifungals</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20717034" target="_blank">PMID:20717034</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Canal cholesteatoma is a rarity in otologic pathology, often leading to misdiagnosis as external otitis or otomycosis by physicians unfamiliar with the disease."</div>
                
                
                <div class="evidence-explanation">Meta-analysis explicitly noting that ear canal cholesteatoma is frequently misdiagnosed as otomycosis, establishing it as a key differential diagnosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        
        <div class="card" id="trials">
            <div class="card-header">
                <div class="card-icon" style="background: #f5f3ff; color: #a855f7;">üî¨</div>
                <h2 class="card-title">Clinical Trials</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT05660382
                    
                    <span class="tag tag-phase">PHASE_III</span>
                    
                    
                    <span class="tag tag-status">RECRUITING</span>
                    
                </div>
                
                <div class="item-desc">Randomized, double-blind, Phase III study evaluating the efficacy and safety of miconazole oil versus placebo in the treatment of otomycosis over 14 days.
</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Pruritus
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0000989" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Ear pain
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0030766" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT05660382" target="_blank">clinicaltrials:NCT05660382</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The goal of this clinical trial is to prove the that miconazole oil works well on fungal infections of the ears, by comparing the drug with a placebo."</div>
                
                
                <div class="evidence-explanation">Phase III trial directly targeting otomycosis treatment with miconazole oil.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT04432376
                    
                    <span class="tag tag-phase">PHASE_III</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Randomized, double-blind, Phase III study evaluating the efficacy and safety of miconazole oil 2% versus vehicle oil in otomycosis treatment, followed by an open-label safety evaluation with 14 days of twice daily application.
</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Pruritus
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0000989" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Conductive hearing impairment
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0000405" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT04432376" target="_blank">clinicaltrials:NCT04432376</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The intention of the study is to evaluate the efficacy of Miconazole Oil on fungal infection of the ears when applied using 5 drops into the ear(s) twice daily for 14 days continuously."</div>
                
                
                <div class="evidence-explanation">Completed Phase III trial evaluating miconazole oil for otomycosis treatment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT01547221
                    
                    <span class="tag tag-phase">NOT_APPLICABLE</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Randomized controlled trial comparing the clinical effectiveness and adverse events of 1% clotrimazole solution versus 3% boric acid in 70% alcohol for the treatment of otomycosis.
</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Pruritus
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0000989" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        Ear pain
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0030766" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT01547221" target="_blank">clinicaltrials:NCT01547221</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Objective is to compare the clinical effectiveness and adverse events of 1% clotrimazole solution versus 3% boric acid in 70% alcohol for the treatment of otomycosis."</div>
                
                
                <div class="evidence-explanation">Completed RCT comparing two standard topical treatments for otomycosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Otomycosis
creation_date: &#34;2026-02-16T00:00:00Z&#34;
updated_date: &#34;2026-02-16T00:00:00Z&#34;
category: Infectious
description: &gt;
  Otomycosis is a superficial fungal infection of the external auditory canal,
  commonly caused by Aspergillus and Candida species. It accounts for approximately
  5-25% of otitis externa cases worldwide, with higher prevalence in tropical and
  subtropical climates. Predisposing factors include prior antibiotic or steroid
  ear drop use, trauma from ear cleaning, and humid environments. Clinical features
  include pruritus, otalgia, otorrhea, and conductive hearing loss due to fungal
  debris obstructing the ear canal. Otomycosis is increasingly recognized as a
  biofilm-related infection, which contributes to treatment failure and recurrence.
  Management centers on thorough aural toilet followed by topical antifungal agents.
disease_term:
  preferred_term: otomycosis
  term:
    id: MONDO:0000262
    label: otomycosis
parents:
- Otitis externa
- Fungal infection
infectious_agent:
- name: Aspergillus species
  infectious_agent_term:
    preferred_term: Aspergillus
    term:
      id: NCBITaxon:5052
      label: Aspergillus
  description: &gt;
    Aspergillus species are the most common causative agents of otomycosis
    worldwide. In a large Chinese series of 452 cases, A. terreus was the most
    common (62.83%), followed by A. flavus (20.35%) and A. niger (12.17%).
    In other geographic regions, A. niger predominates. Species-level
    identification is important because antifungal susceptibility varies
    significantly between species, with approximately 30% resistance to
    topical azoles (bifonazole and clotrimazole) reported for Aspergillus
    isolates. Azole resistance mechanisms include cyp51A mutations and
    overexpression of efflux pump genes (mdr1, mfs) in Aspergillus section
    Nigri.
  evidence:
  - reference: PMID:38578519
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;In the 452 clinical strains isolated from the external ear canal, 284 were identified as Aspergillus terreus (62.83%), 92 as Aspergillus flavus (20.35%), 55 as Aspergillus niger (12.17%).&#34;
    explanation: Large clinical series identifying Aspergillus species distribution in otomycosis, with A. terreus as the most common in central China.
  - reference: PMID:40317309
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Our fungal culture results revealed that, in 83 patients (84.69%), the otomycotic pathogen was Aspergillus&#34;
    explanation: RCT confirming Aspergillus as the dominant pathogen in 84.69% of culture-positive otomycosis cases.
  - reference: PMID:38486086
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: &#34;Black Aspergillus species are the most common etiological agents of otomycosis, and pulmonary aspergillosis.&#34;
    explanation: Study on azole resistance mechanisms in Aspergillus section Nigri, confirming black aspergilli as the most common otomycosis agents.
  - reference: PMID:37257666
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Black aspergilli (section Nigri) are predominate etiologic agents of otomycosis, however, there is controversy in the exact differentiation of species.&#34;
    explanation: Molecular study using calmodulin gene sequencing revealing A. welwitschiae (60.5%) and A. tubingensis (36.0%) as the true predominant species within section Nigri, rather than A. niger sensu stricto.
  - reference: PMID:37108955
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;A. niger is more frequently reported in less severe infections such as otomycosis.&#34;
    explanation: Comprehensive review of non-fumigatus Aspergillus noting A. niger&#39;s association with otomycosis as a less severe infection compared to invasive aspergillosis.
- name: Candida species
  infectious_agent_term:
    preferred_term: Candida
    term:
      id: NCBITaxon:5475
      label: Candida
  description: &gt;
    Candida species are the second most common causative agents of otomycosis,
    accounting for a smaller proportion of cases than Aspergillus. C. parapsilosis
    and C. tropicalis are the most frequently isolated Candida species. Candida
    otomycosis may present with a creamy white discharge rather than the dark
    fungal debris typical of Aspergillus infection. Co-infection with bacteria
    (particularly Staphylococcus) is commonly observed.
  evidence:
  - reference: PMID:38450054
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Aspergillus spp. (average abundance 90.68%) was the dominant fungus involved in otomycosis secretion.&#34;
    explanation: Microbiome study showing fungal community composition in otomycosis, with Aspergillus dominant and Candida as a secondary pathogen.
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;common fungal isolate was Aspergillus niger 9 (45.0%).&#34;
    explanation: Clinical study from Nigeria identifying Aspergillus niger as the most common isolate, with Candida species also identified among causative agents.
  - reference: PMID:37367594
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Candida auris, Candida blankii, and Kodamaea ohmeri have been regarded as emerging fungal pathogens that can cause infections with high mortality.&#34;
    explanation: Molecular typing study identifying emerging Candida species (including C. auris with azole resistance-associated ERG11p Y132F substitution) isolated from otomycosis in Bangladesh.
  - reference: PMID:37223402
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Commonly found fungi belonging to the genus Aspergillus (55%), followed by Candida (45%).&#34;
    explanation: Clinical study showing Candida as the second most common pathogen (45%) after Aspergillus (55%) in otomycosis.
prevalence:
- population: Global
  notes: &gt;
    Otomycosis accounts for 5-20% of otitis externa cases worldwide, with
    higher prevalence in tropical and subtropical regions. A 2024 systematic
    review found the condition is most commonly reported in tropical and
    sub-tropical countries.
  evidence:
  - reference: PMID:39376298
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide.&#34;
    explanation: Systematic review establishing otomycosis as 5-20% of all otitis externa cases.
pathophysiology:
- name: Disruption of cerumen antimicrobial barrier
  description: &gt;
    The external auditory canal is normally protected by cerumen, which maintains
    an acidic pH (mean ~3.95), contains antimicrobial peptides (defensins hBD1-3,
    cathelicidin LL-37, lysozyme, lactoferrin, BPI), and supports colonization
    resistance by resident microbiota. Physical or chemical disruption of this
    barrier by excessive ear cleaning, moisture exposure, or other trauma
    removes the primary antimicrobial defense.
  cell_types:
  - preferred_term: Epithelial cell of external acoustic meatus
    term:
      id: CL:1000434
      label: epithelial cell of external acoustic meatus
  biological_processes:
  - preferred_term: Antimicrobial humoral response
    modifier: DECREASED
    term:
      id: GO:0019730
      label: antimicrobial humoral response
  locations:
  - preferred_term: External acoustic meatus
    term:
      id: UBERON:0001352
      label: external acoustic meatus
  downstream:
  - target: Antibiotic-induced dysbiosis of ear canal microbiota
    description: Loss of cerumen barrier combined with antibiotic exposure disrupts commensal flora.
    evidence:
    - reference: PMID:41596275
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;Both an excess and a deficiency of earwax can lead to dysbiosis of the outer ear, and consequently to the development of various infections.&#34;
      explanation: Links cerumen disruption to dysbiosis and subsequent ear infections.
  evidence:
  - reference: PMID:21298458
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;All ten antimicrobial peptides are present in ear wax. Some of these proteins seem to be merelycell-bound in ear wax. Antimicrobial peptides in ear wax prevent bacteria and fungi from causing infections inthe external auditory canal.&#34;
    explanation: Identifies antimicrobial peptides in cerumen that protect the EAC from fungal infection.
  - reference: PMID:41596275
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Earwax is composed primarily of keratin secreted by epithelial cells and substances secreted by sweat and apocrine glands. It plays a key role in the physiology of the ear canal, maintaining a low pH, limiting moisture, and exhibiting antimicrobial properties.&#34;
    explanation: Confirms cerumen&#39;s antimicrobial role through low pH and antimicrobial properties.
- name: Antibiotic-induced dysbiosis of ear canal microbiota
  description: &gt;
    Ototopical antibiotic use is the most common predisposing factor for
    otomycosis, found in approximately 47% of cases. Antibiotics suppress
    commensal bacteria that normally compete with fungi for nutrients and
    ecological niches, creating a permissive environment for fungal overgrowth.
    The resulting dysbiosis shifts the microbial community from
    bacterial-dominated to fungal-dominated.
  biological_processes:
  - preferred_term: Antimicrobial humoral response
    modifier: DECREASED
    term:
      id: GO:0019730
      label: antimicrobial humoral response
  downstream:
  - target: Fungal colonization of the external auditory canal
    description: Loss of bacterial colonization resistance permits Aspergillus and Candida to establish infection.
    evidence:
    - reference: PMID:41596275
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;The natural ear canal microbiota provides so-called colonization resistance, which protects against invasion by pathogenic microorganisms.&#34;
      explanation: Establishes that normal microbiota provides colonization resistance against pathogens.
  evidence:
  - reference: PMID:39376298
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Aspergillus was the most common species isolated.&#34;
    explanation: Systematic review identifying Aspergillus as the most common pathogen in otomycosis, with ototopical antibiotics as the commonest predisposing factor.
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;50.0% applied ototopic medications before presentation&#34;
    explanation: Clinical study documenting prior ototopical medication use as a predisposing factor in half of patients.
  - reference: PMID:38450054
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Staphylococcus spp. (average abundance 29.05%) was the dominant bacteria and Aspergillus spp. (average abundance 90.68%) was the dominant fungus involved in otomycosis secretion.&#34;
    explanation: Microbiome study demonstrating the dysbiotic shift in otomycosis, with Aspergillus dominating the fungal community and bacterial co-infection by Staphylococcus.
- name: Fungal colonization of the external auditory canal
  description: &gt;
    Aspergillus and Candida species colonize the external auditory canal when
    the microenvironment becomes permissive. Aspergillus species (particularly
    A. niger and A. flavus) are the most commonly isolated pathogens, followed
    by Candida species (particularly C. parapsilosis and C. tropicalis). The
    species distribution varies by geographic region.
  locations:
  - preferred_term: External acoustic meatus
    term:
      id: UBERON:0001352
      label: external acoustic meatus
  downstream:
  - target: Biofilm formation and antifungal resistance
    description: Colonizing fungi develop biofilm structures that provide structural protection and drug resistance.
    evidence:
    - reference: PMID:36080191
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: &#34;The Aspergillus section Nigri causes otomycosis localized in the external auditory canal.&#34;
      explanation: Establishes Aspergillus section Nigri as a cause of otomycosis leading to biofilm formation.
  evidence:
  - reference: PMID:39376298
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Aspergillus was the most common species isolated.&#34;
    explanation: Systematic review confirming Aspergillus as the predominant causative agent.
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;common fungal isolate was Aspergillus niger 9 (45.0%).&#34;
    explanation: Clinical study confirming A. niger as the most common fungal isolate.
- name: Biofilm formation and antifungal resistance
  description: &gt;
    Colonizing fungi form biofilms on the ear canal epithelium. The biofilm
    extracellular matrix acts as a diffusion barrier that reduces antifungal
    drug penetration and mediates phenotypic drug resistance. This biofilm-mediated
    resistance contributes to treatment failure and recurrence rates of
    approximately 15%.
  biological_processes:
  - preferred_term: Biofilm formation
    modifier: INCREASED
    term:
      id: GO:0042710
      label: biofilm formation
  downstream:
  - target: Local innate immune activation
    description: Biofilm persistence and fungal biomass accumulation provoke host inflammatory response.
    evidence:
    - reference: PMID:36080191
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: &#34;the PLGA-NPs system can increase the bioavailability of PTB in Aspergillus section Nigri biofilm by overcoming the biofilm matrix barrier and delivering PTB to fungal cells.&#34;
      explanation: Demonstrates that biofilm matrix acts as a barrier, confirming biofilm persistence leads to continued host exposure.
  evidence:
  - reference: PMID:36080191
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: &#34;the PLGA-NPs system can increase the bioavailability of PTB in Aspergillus section Nigri biofilm by overcoming the biofilm matrix barrier and delivering PTB to fungal cells.&#34;
    explanation: Demonstrates that Aspergillus biofilm matrix acts as a barrier to antifungal agents, necessitating nanoparticle delivery to penetrate it.
  - reference: PMID:36632528
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;otomycosis relapsed even after six months of continuous systemic antifungal treatment with therapeutic drug levels and without treatment interruption; and only resolved after application of topical voriconazole&#34;
    explanation: Case report demonstrating that biofilm-mediated resistance can cause otomycosis relapse despite prolonged systemic therapy, supporting the clinical significance of biofilm as a treatment barrier.
- name: Local innate immune activation
  description: &gt;
    Fungal hyphae, spores, and biofilm debris provoke local innate immune
    activation in the external auditory canal. Neutrophils and other innate
    immune cells are recruited to the site, producing inflammatory mediators
    that cause tissue edema, erythema, and pain. The host defense response
    to fungus is activated but insufficient to clear the biofilm-protected
    infection.
  biological_processes:
  - preferred_term: Defense response to fungus
    modifier: INCREASED
    term:
      id: GO:0050832
      label: defense response to fungus
  cell_types:
  - preferred_term: Neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  downstream:
  - target: Canal obstruction and symptom manifestation
    description: Inflammatory exudate combines with fungal biomass to obstruct the ear canal.
    evidence:
    - reference: PMID:21298458
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;If this local defence system fails, infections of the external auditory canal may result.&#34;
      explanation: Failure of local defense leads to progressive EAC infection and inflammatory consequences.
  evidence:
  - reference: PMID:21298458
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;If this local defence system fails, infections of the external auditory canal may result.&#34;
    explanation: Failure of the cerumen antimicrobial defense system leads to EAC infections with consequent inflammation.
- name: Canal obstruction and symptom manifestation
  description: &gt;
    The combination of fungal biomass (hyphae, spores, conidiophores),
    inflammatory exudate, and desquamated epithelium accumulates in the
    external auditory canal, producing the characteristic clinical symptoms
    of pruritus, otalgia, discharge, and conductive hearing impairment. The
    degree of obstruction correlates with the severity of hearing loss.
  locations:
  - preferred_term: External acoustic meatus
    term:
      id: UBERON:0001352
      label: external acoustic meatus
  evidence:
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;common presenting complaint was itchy ear (33.8%). Majority of patients (85.9%) had unilateral ear involvement&#34;
    explanation: Clinical study documenting the symptomatic presentation of otomycosis including pruritus and laterality.
phenotypes:
- name: Pruritus
  description: &gt;
    Itching of the external auditory canal is frequently the predominant and
    earliest symptom. It results from local epithelial irritation and
    inflammation caused by fungal colonization.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Pruritus
    term:
      id: HP:0000989
      label: Pruritus
  evidence:
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;common presenting complaint was itchy ear (33.8%).&#34;
    explanation: Pruritus was the most common presenting complaint in this clinical series.
  - reference: PMID:38375517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;clotrimazole has the best or most significant effect on the treatment of otomycosis for patients suffering from pain, itching, swelling, and hearing loss.&#34;
    explanation: Itching listed as a core symptom of otomycosis.
- name: Ear pain
  description: &gt;
    Otalgia is a common symptom, typically less severe than in bacterial otitis
    externa. It results from inflammation of the EAC skin.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Ear pain
    term:
      id: HP:0030766
      label: Ear pain
  evidence:
  - reference: PMID:38375517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;clotrimazole has the best or most significant effect on the treatment of otomycosis for patients suffering from pain, itching, swelling, and hearing loss.&#34;
    explanation: Pain listed as a core symptom of otomycosis.
- name: Conductive hearing impairment
  description: &gt;
    Hearing impairment results from obstruction of the ear canal by fungal
    debris, hyphae, biofilm, and inflammatory material. It is typically
    reversible with treatment.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Conductive hearing impairment
    term:
      id: HP:0000405
      label: Conductive hearing impairment
  evidence:
  - reference: PMID:38375517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;clotrimazole has the best or most significant effect on the treatment of otomycosis for patients suffering from pain, itching, swelling, and hearing loss.&#34;
    explanation: Hearing loss listed as a core symptom of otomycosis.
environmental:
- name: Topical antibiotic use
  description: &gt;
    Prolonged use of ototopical antibiotics (with or without steroids) is the
    most common predisposing factor, disrupting the normal bacterial flora and
    permitting fungal overgrowth.
  evidence:
  - reference: PMID:39376298
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Aspergillus was the most common species isolated.&#34;
    explanation: Systematic review identifies Aspergillus as the predominant pathogen, with ototopical antibiotics as the commonest predisposing factor (47% pooled estimate).
- name: Humid tropical climate
  description: &gt;
    Hot, humid environments promote moisture retention in the ear canal, which
    disrupts cerumen function and provides a favorable niche for fungal growth.
  evidence:
  - reference: PMID:39376298
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Most of the studies were conducted in tropical and sub-tropical countries.&#34;
    explanation: Systematic review confirming tropical/subtropical predominance.
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Otomycosis is common in environments with hot, humid weather&#34;
    explanation: Clinical study confirming association with hot, humid environments.
- name: Ear canal trauma from cleaning
  description: &gt;
    Compulsive ear cleaning and instrumentation damage the epithelial lining
    and remove protective cerumen, predisposing to fungal colonization.
  evidence:
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;50.0% applied ototopic medications before presentation&#34;
    explanation: Clinical study documenting prior medication use as a predisposing factor.
treatments:
- name: Aural toilet and debridement
  description: &gt;
    Thorough mechanical debridement of fungal debris from the external auditory
    canal is the cornerstone of treatment and essential for topical antifungal
    efficacy. The most common treatment modality used in clinical practice.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
  evidence:
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The most common treatment was local ear debridement and use of topical antifungal creams. Majority (91.5%) of the patients responded with resolution of fungal infection.&#34;
    explanation: Clinical study confirming debridement plus topical antifungal as standard of care with 91.5% resolution.
  - reference: PMID:40317309
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;In the lavage group, 48 (48/52, 92.30%) patients were cured with initial treatment after three months of follow-up&#34;
    explanation: RCT demonstrating that ear canal lavage alone achieves 92.30% cure rate, comparable to lavage plus topical antifungal.
- name: Topical antifungal therapy
  description: &gt;
    Topical clotrimazole is the most commonly used antifungal agent. Other
    options include miconazole and nystatin. Systemic triazoles (fluconazole,
    itraconazole) are reserved for severe or refractory disease.
  treatment_term:
    preferred_term: topical pharmacotherapy
    term:
      id: MAXO:0001573
      label: topical pharmacotherapy
    therapeutic_agent:
    - preferred_term: clotrimazole
      term:
        id: CHEBI:3764
        label: clotrimazole
    - preferred_term: miconazole
      term:
        id: CHEBI:6923
        label: miconazole
  evidence:
  - reference: PMID:38375517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Eight studies had similar results and claimed that clotrimazole has the best or most significant effect on the treatment of otomycosis&#34;
    explanation: Review supporting clotrimazole as the most effective topical treatment for otomycosis.
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The most common treatment was local ear debridement and use of topical antifungal creams.&#34;
    explanation: Confirms topical antifungal creams as standard clinical practice.
  - reference: PMID:41019825
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;In the 12th week after treatment, 76.34% of the 10% povidone-iodine group and 85.26% of the Clotrimazole group had a good response to treatment (p = 0.248).&#34;
    explanation: RCT showing clotrimazole achieves 85.26% response rate at 12 weeks, with povidone-iodine as a comparable alternative (76.34%, no significant difference).
- name: Acidifying agents
  description: &gt;
    Acidifying agents such as 2% acetic acid or boric acid alcohol solutions
    are used as alternatives to antifungals, particularly for mild cases or
    antifungal-resistant species. They restore the acidic pH of the ear canal
    that inhibits fungal growth.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    therapeutic_agent:
    - preferred_term: acetic acid
      term:
        id: CHEBI:15366
        label: acetic acid
    - preferred_term: boric acid
      term:
        id: CHEBI:33118
        label: boric acid
  evidence:
  - reference: PMID:38375517
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;in the biomedical field, the re-emerging investigation attention is due to the statements of a number of mechanisms defending the use of acidifying agents to treat mycosis (of antifungal-resistant species).&#34;
    explanation: Supports acidifying agents as an alternative treatment approach, especially for resistant cases.
differential_diagnoses:
- name: Acute bacterial otitis externa
  description: &gt;
    Bacterial otitis externa presents with similar symptoms of ear pain,
    discharge, and canal edema. It is typically caused by Pseudomonas
    aeruginosa or Staphylococcus aureus and produces purulent rather than
    fungal debris. Bacterial infection tends to cause more severe pain
    and canal edema than otomycosis.
  disease_term:
    preferred_term: acute otitis externa
    term:
      id: MONDO:0001051
      label: acute otitis externa
  distinguishing_features:
  - Purulent discharge rather than fungal debris (hyphae, spores)
  - More severe pain and canal edema
  - Responds to topical antibiotics rather than antifungals
  - Absence of characteristic fungal mat on otoscopy
  evidence:
  - reference: PMID:39376298
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide.&#34;
    explanation: Otomycosis represents a subset of otitis externa, requiring differentiation from the more common bacterial form.
- name: Seborrheic dermatitis
  description: &gt;
    Seborrheic dermatitis of the external ear can mimic otomycosis with
    pruritus, scaling, and flaking. It involves Malassezia yeast but
    is a chronic inflammatory dermatosis rather than a true fungal
    infection of the canal.
  disease_term:
    preferred_term: seborrheic dermatitis
    term:
      id: MONDO:0006608
      label: seborrheic dermatitis
  distinguishing_features:
  - Scaling and flaking extends to conchal bowl and postauricular area
  - Absence of fungal hyphae or conidiophores on microscopy
  - Responds to topical steroids and antifungal shampoos
  evidence:
  - reference: PMID:33112026
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Among the main dermatoses that can affect EAC seborrheic dermatitis, psoriasis, irritant or allergic contact dermatitis, chronic external otitis (atrial eczematoid dermatitis) and cutaneous lupus should be considered.&#34;
    explanation: Clinical study identifying seborrheic dermatitis as the most common (56% of cases) erythematous-squamous dermatosis of the external auditory canal, presenting with symptoms overlapping otomycosis.
- name: Contact dermatitis of the ear canal
  description: &gt;
    Allergic or irritant contact dermatitis from hearing aids, ear drops,
    or earrings can present with pruritus, erythema, and discharge similar
    to otomycosis. History of allergen exposure and patch testing help
    differentiate.
  disease_term:
    preferred_term: contact dermatitis
    term:
      id: MONDO:0005480
      label: contact dermatitis
  distinguishing_features:
  - History of allergen or irritant exposure (hearing aids, ear drops, jewelry)
  - Absence of fungal elements on microscopy and culture
  - Responds to allergen avoidance and topical corticosteroids
  evidence:
  - reference: PMID:33112026
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Among the main dermatoses that can affect EAC seborrheic dermatitis, psoriasis, irritant or allergic contact dermatitis, chronic external otitis (atrial eczematoid dermatitis) and cutaneous lupus should be considered.&#34;
    explanation: Clinical study listing allergic contact dermatitis among the main erythematous-squamous disorders of the EAC that must be differentiated from infectious causes.
  - reference: PMID:1601193
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Hearing aid users with longstanding and severe dermatitis in the ear canal were examined by a dermatologist and patch tested.&#34;
    explanation: Study documenting allergic contact dermatitis from hearing aid earmolds causing ear canal dermatitis, a key differential for otomycosis in hearing aid users.
- name: Cholesteatoma
  description: &gt;
    Cholesteatoma can present with chronic otorrhea, hearing loss, and
    debris in the ear canal. Unlike otomycosis, it involves keratinized
    squamous epithelium in the middle ear and can cause bone erosion and
    serious complications.
  disease_term:
    preferred_term: cholesteatoma
    term:
      id: MONDO:0006530
      label: cholesteatoma
  distinguishing_features:
  - Pearly white keratin mass typically arising from the pars flaccida
  - Associated with chronic otitis media and tympanic membrane perforation
  - CT imaging shows soft tissue mass with possible bone erosion
  - Requires surgical management rather than topical antifungals
  evidence:
  - reference: PMID:20717034
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Canal cholesteatoma is a rarity in otologic pathology, often leading to misdiagnosis as external otitis or otomycosis by physicians unfamiliar with the disease.&#34;
    explanation: Meta-analysis explicitly noting that ear canal cholesteatoma is frequently misdiagnosed as otomycosis, establishing it as a key differential diagnosis.
definitions:
- name: Clinical diagnostic criteria for otomycosis
  definition_type: DIAGNOSTIC_CRITERIA
  description: &gt;
    Otomycosis is diagnosed clinically based on characteristic otoscopic
    findings combined with symptomatology and confirmed by mycological
    culture. No single internationally standardized diagnostic criteria
    set exists; diagnosis relies on the triad of compatible symptoms,
    characteristic otoscopic appearance, and positive fungal culture
    or microscopy.
  scope: adults and children
  inclusion_criteria:
  - preferred_term: External ear canal irritation symptoms
    description: &gt;
      Symptoms of external ear canal irritation including pruritus,
      otalgia, otorrhea, or aural fullness.
  - preferred_term: Characteristic otoscopic findings
    description: &gt;
      Characteristic otoscopic findings including fungal debris, hyphae,
      spores, or conidiophores visible in the external auditory canal.
  - preferred_term: Positive fungal identification
    description: &gt;
      Positive fungal culture or direct microscopy showing fungal
      elements (KOH preparation or Gram stain).
  exclusion_criteria:
  - preferred_term: Middle ear pathology as primary source
    description: &gt;
      Otitis media or middle ear pathology as the primary source
      of symptoms.
  - preferred_term: Necrotizing otitis externa
    description: &gt;
      Malignant otitis externa (necrotizing otitis externa) with
      bone involvement.
  evidence:
  - reference: PMID:38962337
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;common presenting complaint was itchy ear (33.8%). Majority of patients (85.9%) had unilateral ear involvement&#34;
    explanation: Clinical study documenting the typical diagnostic presentation of otomycosis.
  - reference: PMID:39376298
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide.&#34;
    explanation: Systematic review establishing the clinical definition of otomycosis.
  - reference: PMID:40317309
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;This study demonstrated that the diagnosis of otomycosis requires vigilance from clinicians given its nonspecific or minor symptoms.&#34;
    explanation: RCT noting the diagnostic challenge of otomycosis due to nonspecific symptoms, supporting the need for systematic diagnostic criteria.
  - reference: PMID:41452477
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;These features (especially crusts, congestion, swelling, and fungoid substance) were significantly associated with fungal positivity.&#34;
    explanation: Large retrospective study identifying otoendoscopic features significantly associated with fungal positivity, supporting otoscopic findings as a diagnostic criterion.
  - reference: PMID:36060244
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: &#34;the average accuracy of the overall validation sample reached 92.42%.&#34;
    explanation: Deep learning model achieving 92.42% diagnostic accuracy for otomycosis using otoendoscopic images, distinguishing otomycosis from impacted cerumen, external otitis, and normal ear canals.
clinical_trials:
- name: NCT05660382
  phase: PHASE_III
  status: RECRUITING
  description: &gt;
    Randomized, double-blind, Phase III study evaluating the efficacy and safety
    of miconazole oil versus placebo in the treatment of otomycosis over 14 days.
  target_phenotypes:
  - preferred_term: Pruritus
    term:
      id: HP:0000989
      label: Pruritus
  - preferred_term: Ear pain
    term:
      id: HP:0030766
      label: Ear pain
  evidence:
  - reference: clinicaltrials:NCT05660382
    supports: SUPPORT
    snippet: &#34;The goal of this clinical trial is to prove the that miconazole oil works well on fungal infections of the ears, by comparing the drug with a placebo.&#34;
    explanation: Phase III trial directly targeting otomycosis treatment with miconazole oil.
- name: NCT04432376
  phase: PHASE_III
  status: COMPLETED
  description: &gt;
    Randomized, double-blind, Phase III study evaluating the efficacy and safety
    of miconazole oil 2% versus vehicle oil in otomycosis treatment, followed by
    an open-label safety evaluation with 14 days of twice daily application.
  target_phenotypes:
  - preferred_term: Pruritus
    term:
      id: HP:0000989
      label: Pruritus
  - preferred_term: Conductive hearing impairment
    term:
      id: HP:0000405
      label: Conductive hearing impairment
  evidence:
  - reference: clinicaltrials:NCT04432376
    supports: SUPPORT
    snippet: &#34;The intention of the study is to evaluate the efficacy of Miconazole Oil on fungal infection of the ears when applied using 5 drops into the ear(s) twice daily for 14 days continuously.&#34;
    explanation: Completed Phase III trial evaluating miconazole oil for otomycosis treatment.
- name: NCT01547221
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: &gt;
    Randomized controlled trial comparing the clinical effectiveness and adverse
    events of 1% clotrimazole solution versus 3% boric acid in 70% alcohol for
    the treatment of otomycosis.
  target_phenotypes:
  - preferred_term: Pruritus
    term:
      id: HP:0000989
      label: Pruritus
  - preferred_term: Ear pain
    term:
      id: HP:0030766
      label: Ear pain
  evidence:
  - reference: clinicaltrials:NCT01547221
    supports: SUPPORT
    snippet: &#34;Objective is to compare the clinical effectiveness and adverse events of 1% clotrimazole solution versus 3% boric acid in 70% alcohol for the treatment of otomycosis.&#34;
    explanation: Completed RCT comparing two standard topical treatments for otomycosis.
notes: &gt;
  Aspergillus species (particularly A. niger and A. flavus) and Candida species
  (particularly C. parapsilosis and C. tropicalis) are the most common causative
  agents. The species distribution varies by geographic region. Molecular
  taxonomy using calmodulin gene sequencing has revealed that many isolates
  previously identified as A. niger are actually A. welwitschiae or A.
  tubingensis (PMID:37257666), which has implications for antifungal susceptibility
  profiling. Emerging Candida species including C. auris (with ERG11p Y132F
  azole resistance mutation) have been isolated from otomycosis cases in
  South Asia (PMID:37367594). Cerumen contains a broad repertoire of
  antimicrobial proteins including defensins (hBD1-3), cathelicidin LL-37,
  lysozyme, lactoferrin, BPI, and immunoglobulins (IgA, IgG). The ABCC11 gene
  polymorphism determines earwax phenotype (wet vs dry) and is associated with
  differences in ear canal microbiota composition, potentially modifying
  susceptibility. Antifungal resistance mechanisms include cyp51A alterations
  in Aspergillus species and biofilm-mediated phenotypic resistance. In a large
  Chinese series (PMID:38578519), topical azole resistance was approximately
  30% among Aspergillus isolates, and cyp51A mutations combined with mdr1/mfs
  efflux pump overexpression contribute to multifactorial azole resistance in
  Aspergillus section Nigri (PMID:38486086). Povidone-iodine (10%) has been
  shown to be a viable alternative to clotrimazole in resource-limited settings
  (PMID:41019825), and nanocrystalline silver demonstrated 89% cure rates in a
  100-patient series (PMID:37223402). Deep learning models using otoendoscopic
  images can achieve 92.42% diagnostic accuracy (PMID:36060244). Novel
  therapeutic approaches under investigation include pterostilbene-loaded PLGA
  nanoparticles that can penetrate fungal biofilm matrix. Refractory cases may
  require topical voriconazole even after prolonged systemic therapy fails
  (PMID:36632528).
classifications:
  harrisons_chapter:
  - classification_value: infectious disease
    evidence:
    - reference: PMID:39376298
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide.&#34;
      explanation: Otomycosis is classified as a fungal infectious disease.
  - classification_value: fungal infectious disease
    evidence:
    - reference: PMID:39376298
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide.&#34;
      explanation: Specifically a fungal infection of the external ear.
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Otomycosis.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>